VRD AUTO SPORTSBusiness Directories,Company Directories

Company Name: Corporate Name:	VRD AUTO SPORTS
Company Title:
Company Description:
Keywords to Search:
Company Address:	186 King St E,HAMILTON,ON,Canada
ZIP Code: Postal Code:	L8N
Telephone Number:	9053089767
Fax Number:
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	0
USA SIC Description:	DISCOUNT STORES
Number of Employees:
Sales Amount:	$1 to 2.5 million
Credit History: Credit Report:	Unknown
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
VUJOVIC B
VUJNOVIC, MILKA
VUJOVIC & VUJOVIC

Next company profile:
VRANCOR REAL ESTATE GROUP
VRANICH ENTERPRISES INC
VPLUS SUNOCO

Company News:

RVd or VRd treatment for Multiple Myeloma | ChemoExperts
How does RVd work? Bortezomib is a conventional chemotherapy drug designed to kill or slow the growth of myeloma cells Lenalidomide is a targeted therapy that works to enhance your immune system to help kill myeloma cells Dexamethasone is a type of corticosteroid that helps stops cancer cells from growing R - Revlimid® (lenalidomide) V - Velcade® (bortezomib) d - dexamethasone (Deltasone
Homepage Vail Recreation District
Groups Private Events Looking for a unique venue in Vail for a special event or gathering? The VRD offers a variety of venues for both large and small-scale events from birthday parties to family reunions, from weddings to corporate retreats, from sports tournaments to concerts Read more » Follow Us on Instagram
VRd for multiple myeloma: Uses and side effects
VRd is a targeted treatment therapy that combines three drugs Read about who can benefit, side effects, the VRd cycle, and more
Understanding the VRd Regimen | Intl myeloma Fn
The “triplet” (3-drug) combination of Velcade® (bortezomib) + Revlimid® (lenalidomide) + dexamethasone [VRd] is a highly effective and well-tolerated therapy for patients with newly diagnosed multiple myeloma (NDMM) Each drug has a different way of attacking myeloma, and each enhances the activity of the other drugs in this combination therapy Currently, while VRd is still used in some
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for . . .
Daratumumab, a monoclonal antibody targeting CD38, has been approved for use with standard myeloma regimens An evaluation of subcutaneous daratumumab combined with bortezomib, lenalidomide, and de
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for . . .
Bortezomib, lenalidomide, and dexamethasone (VRd) is a preferred first-line treatment option for patients with newly diagnosed multiple myeloma Whether the addition of the anti-CD38 monoclonal ant
Comparing VTD and VRD Regimens in Multiple Myeloma Treatment
Medically reviewed by Dr Shani Saks on Feb 21, 2025 A recent meta-analysis evaluated the efficacy and safety of two induction regimens: bortezomib, thalidomide, and dexamethasone (VTD) and bortezomib, lenalidomide, and dexamethasone (VRD), in transplant-eligible patients with newly diagnosed multiple myeloma (NDMM) The study assessed response rates, autologous hematopoietic stem cell
Daratumumab Plus Standard Therapy for Multiple Myeloma
Adding daratumumab (Darzalex) to standard VRD treatment helped people with newly diagnosed multiple myeloma live longer without their cancer getting worse or dying
vRad | Client Access Portal
The vRad Portal gives clients access to the Order Management, Quality Assurance, Reporting and other client applications